Cargando…
Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
Some long non-coding RNAs (lncRNAs) have been documented to be involved in cancer progression and anticancer drug resistance in hepatocellular carcinoma (HCC). Thus, approaches designed to target these genes may facilitate the development of promising strategies for treating HCC. Previously, we show...
Autores principales: | Tao, Haisu, Zhang, Yuxin, Li, Jiang, Liu, Junjie, Yuan, Tong, Wang, Wenqiang, Liang, Huifang, Zhang, Erlei, Huang, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852557/ https://www.ncbi.nlm.nih.gov/pubmed/36699616 http://dx.doi.org/10.1016/j.omto.2022.12.005 |
Ejemplares similares
-
Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022) -
Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023) -
Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis
por: Tao, Haisu, et al.
Publicado: (2021) -
Clinical significance and effect of lncRNA BBOX1-AS1 on the proliferation and migration of lung squamous cell carcinoma
por: Zhang, Yu, et al.
Publicado: (2022) -
Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis
por: Shi, Zhi-Liang, et al.
Publicado: (2022)